HD10: Investigating reduction of combined modality treatment intensity in early stage Hodgkin's Lymphoma.  Interim analysis of a randomized trial of the German Hodgkin's Study Group (GHSG)

Reviewer: Ryan Smith , MD
Ultima Vez Modificado: 14 de mayo del 2005

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015